Skip to main content
Top
Published in: Annals of Surgical Oncology 5/2015

01-05-2015 | Medical Oncology

Local Low-Dose Thrombolysis for Safe and Effective Treatment of Venous Port-Catheter Thrombosis

Authors: Alexander Massmann, MD, Philippe Jagoda, MD, Nicole Kranzhoefer, MD, Arno Buecker, MD

Published in: Annals of Surgical Oncology | Issue 5/2015

Login to get access

Abstract

Purpose

Retrospective evaluation of local low-dose thrombolysis for treatment of venous port-catheter thrombosis.

Methods

A total of 1,031 patients with dysfunctional port systems underwent port angiography depicting 181 patients with thrombosis around the port-catheter. A total of 165 patients (male 35, female 130; age 57.3 ± 12.9 [20–83] years) underwent thrombolysis by single injection of 3 mg alteplase into the port system. Patients were followed up by clinical and angiographic/radiological port controls the next day and 12.9 ± 17.9 [1–81] months on the basis of regular oncologic staging examinations.

Results

Thrombosis occurred 10.1 ± 19.3 [median 2.9] months after port implantation and was clinically suspected by difficult blood aspiration in 146 of 181 (80.7 %) and high resistance to injection fluids in 75 (41.4 %) patients. A predictor for angiographically confirmed port-catheter thrombosis was a combination of both (73, 40.3 % patients) (Fisher’s exact test p < 0.0001; positive predictive value 0.8977), or suboptimal (not cavoatrial) port-catheter position (92, 50.8 % patients) (p = 0.0047; positive predictive value 0.8276). The cumulative success rate of thrombolysis was 92.7 % (153 of 165 patients). Initial thrombolysis was effective in 127 (77.0 %) patients. Repeated (up to 6 times) thrombolysis was effective in 26 of 31 patients after second or third thrombolysis. Extensive central venous thrombosis (9 patients) predicted ineffective thrombolysis (p < 0.0001). Primary patency of successfully treated devices was 92.8 % at 1 month and 84.9 % at 3 months. Rethrombosis occurred in 27 patients after 4.4 ± 6.6 (median 1.8) months. Primary rethrombolysis was effective in 22 (81.5 %) patients. Cumulative patency was 100 % at 3 months.

Conclusions

Difficult aspiration combined with high resistance to injection fluids or suboptimal port-catheter position are strong independent predictors for port-catheter thrombosis. Local low-dose thrombolysis or repeat thrombolysis is safe and effective in the absence of large central venous thrombosis.
Literature
1.
go back to reference Kock HJ, Pietsch M, Krause U, Wilke H, Eigler FW. Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems. World J Surg. 1998;22:12–6.CrossRefPubMed Kock HJ, Pietsch M, Krause U, Wilke H, Eigler FW. Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems. World J Surg. 1998;22:12–6.CrossRefPubMed
2.
go back to reference Stein M, Wagner RH. [Complications of central venous access devices: outcome analysis of 2359 implantations]. Dtsch Med Wochenschr. 2005;130:1129–32.CrossRefPubMed Stein M, Wagner RH. [Complications of central venous access devices: outcome analysis of 2359 implantations]. Dtsch Med Wochenschr. 2005;130:1129–32.CrossRefPubMed
3.
go back to reference Vardy J, Engelhardt K, Cox K, Jacquet J, McDade A, Boyer M, et al. Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature. Br J Cancer. 2004;91:1045–9.PubMedCentralPubMed Vardy J, Engelhardt K, Cox K, Jacquet J, McDade A, Boyer M, et al. Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature. Br J Cancer. 2004;91:1045–9.PubMedCentralPubMed
4.
go back to reference Moureau N, Poole S, Murdock MA, Gray SM, Semba CP. Central venous catheters in home infusion care: outcomes analysis in 50,470 patients. J Vasc Interv Radiol. 2002;13:1009–16.CrossRefPubMed Moureau N, Poole S, Murdock MA, Gray SM, Semba CP. Central venous catheters in home infusion care: outcomes analysis in 50,470 patients. J Vasc Interv Radiol. 2002;13:1009–16.CrossRefPubMed
5.
go back to reference Wieners G, Redlich U, Dudeck O, Schütte K, Ricke J, Pech M. [First experiences with intravenous port systems authorized for high pressure injection of contrast agent in multiphasic computed tomography]. Rofo. 2009;181:664–8.CrossRefPubMed Wieners G, Redlich U, Dudeck O, Schütte K, Ricke J, Pech M. [First experiences with intravenous port systems authorized for high pressure injection of contrast agent in multiphasic computed tomography]. Rofo. 2009;181:664–8.CrossRefPubMed
6.
go back to reference Lenhart M, Schätzler S, Manke C, Strotzer M, Seitz J, Gmeinwieser J, et al. [Radiological placement of peripheral central venous access ports at the forearm. Technical results and long term outcome in 391 patients]. Rofo. 2010;182:20–8.CrossRefPubMed Lenhart M, Schätzler S, Manke C, Strotzer M, Seitz J, Gmeinwieser J, et al. [Radiological placement of peripheral central venous access ports at the forearm. Technical results and long term outcome in 391 patients]. Rofo. 2010;182:20–8.CrossRefPubMed
7.
go back to reference Daeihagh P, Jordan J, Chen J, Rocco M. Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters. Am J Kidney Dis. 2000;36:75–9.CrossRefPubMed Daeihagh P, Jordan J, Chen J, Rocco M. Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters. Am J Kidney Dis. 2000;36:75–9.CrossRefPubMed
8.
go back to reference Gabrail N, Sandler E, Charu V, Anas N, Lim E, Blaney M, et al. TROPICS 1: a phase III, randomized, double-blind, placebo-controlled study of tenecteplase for restoration of function in dysfunctional central venous catheters. J Vasc Interv Radiol. 2010;21:1852–8.CrossRefPubMed Gabrail N, Sandler E, Charu V, Anas N, Lim E, Blaney M, et al. TROPICS 1: a phase III, randomized, double-blind, placebo-controlled study of tenecteplase for restoration of function in dysfunctional central venous catheters. J Vasc Interv Radiol. 2010;21:1852–8.CrossRefPubMed
9.
go back to reference Glaser DW, Medeiros D, Rollins N, Buchanan GR. Catheter-related thrombosis in children with cancer. J Pediatr. 2001;138:255–9.CrossRefPubMed Glaser DW, Medeiros D, Rollins N, Buchanan GR. Catheter-related thrombosis in children with cancer. J Pediatr. 2001;138:255–9.CrossRefPubMed
10.
go back to reference Gray RJ, Levitin A, Buck D, Brown LC, Sparling YH, Jablonski KA, et al. Percutaneous fibrin sheath stripping versus transcatheter urokinase infusion for malfunctioning well-positioned tunneled central venous dialysis catheters: a prospective, randomized trial. J Vasc Interv Radiol. 2000;11:1121–9.CrossRefPubMed Gray RJ, Levitin A, Buck D, Brown LC, Sparling YH, Jablonski KA, et al. Percutaneous fibrin sheath stripping versus transcatheter urokinase infusion for malfunctioning well-positioned tunneled central venous dialysis catheters: a prospective, randomized trial. J Vasc Interv Radiol. 2000;11:1121–9.CrossRefPubMed
11.
go back to reference Semba CP, Deitcher SR, Li X, Resnansky L, Tu T, McCluskey ER. Treatment of occluded central venous catheters with alteplase: results in 1,064 patients. J Vasc Interv Radiol. 2002;13:1199–205.CrossRefPubMed Semba CP, Deitcher SR, Li X, Resnansky L, Tu T, McCluskey ER. Treatment of occluded central venous catheters with alteplase: results in 1,064 patients. J Vasc Interv Radiol. 2002;13:1199–205.CrossRefPubMed
12.
go back to reference Tumlin J, Goldman J, Spiegel DM, Roer D, Ntoso KA, Blaney M, et al. A phase III, randomized, double-blind, placebo-controlled study of tenecteplase for improvement of hemodialysis catheter function: TROPICS 3. Clin J Am Soc Nephrol. 2010;5:631–6.CrossRefPubMedCentralPubMed Tumlin J, Goldman J, Spiegel DM, Roer D, Ntoso KA, Blaney M, et al. A phase III, randomized, double-blind, placebo-controlled study of tenecteplase for improvement of hemodialysis catheter function: TROPICS 3. Clin J Am Soc Nephrol. 2010;5:631–6.CrossRefPubMedCentralPubMed
13.
go back to reference Whigham CJ, Lindsey JI, Goodman CJ, Fisher RG. Venous port salvage utilizing low dose tPA. Cardiovasc Interv Radiol. 2002;25:513–6.CrossRefPubMed Whigham CJ, Lindsey JI, Goodman CJ, Fisher RG. Venous port salvage utilizing low dose tPA. Cardiovasc Interv Radiol. 2002;25:513–6.CrossRefPubMed
14.
go back to reference Zajko AB, Reilly JJ Jr, Bron KM, Desai R, Steed DL. Low-dose streptokinase for occluded Hickman catheters. AJR Am J Roentgenol. 1983;141:1311–2.CrossRefPubMed Zajko AB, Reilly JJ Jr, Bron KM, Desai R, Steed DL. Low-dose streptokinase for occluded Hickman catheters. AJR Am J Roentgenol. 1983;141:1311–2.CrossRefPubMed
15.
go back to reference Crain MR, Mewissen MW, Ostrowski GJ, Paz-Fumagalli R, Beres RA, Wertz RA. Fibrin sleeve stripping for salvage of failing hemodialysis catheters: technique and initial results. Radiology. 1996;198:41–4.CrossRefPubMed Crain MR, Mewissen MW, Ostrowski GJ, Paz-Fumagalli R, Beres RA, Wertz RA. Fibrin sleeve stripping for salvage of failing hemodialysis catheters: technique and initial results. Radiology. 1996;198:41–4.CrossRefPubMed
16.
go back to reference Johnstone RD, Stewart GA, Akoh JA, Fleet M, Akyol M, Moss JG. Percutaneous fibrin sleeve stripping of failing haemodialysis catheters. Nephrol Dial Transplant. 1999;14:688–91.CrossRefPubMed Johnstone RD, Stewart GA, Akoh JA, Fleet M, Akyol M, Moss JG. Percutaneous fibrin sleeve stripping of failing haemodialysis catheters. Nephrol Dial Transplant. 1999;14:688–91.CrossRefPubMed
17.
go back to reference Knelson MH, Hudson ER, Suhocki PV, Payne CS, Sallee DS, Newman GE. Functional restoration of occluded central venous catheters: new interventional techniques. J Vasc Interv Radiol. 1995;6:623–7.CrossRefPubMed Knelson MH, Hudson ER, Suhocki PV, Payne CS, Sallee DS, Newman GE. Functional restoration of occluded central venous catheters: new interventional techniques. J Vasc Interv Radiol. 1995;6:623–7.CrossRefPubMed
18.
go back to reference Merport M, Murphy TP, Egglin TK, Dubel GJ. Fibrin sheath stripping versus catheter exchange for the treatment of failed tunneled hemodialysis catheters: randomized clinical trial. J Vasc Interv Radiol. 2000;11:1115–20.CrossRefPubMed Merport M, Murphy TP, Egglin TK, Dubel GJ. Fibrin sheath stripping versus catheter exchange for the treatment of failed tunneled hemodialysis catheters: randomized clinical trial. J Vasc Interv Radiol. 2000;11:1115–20.CrossRefPubMed
19.
go back to reference Rockall AG, Harris A, Wetton CW, Taube D, Gedroyc W, Al-Kutoubi MA. Stripping of failing haemodialysis catheters using the Ampltaz gooseneck snare. Clin Radiol. 1997;52:616–20.CrossRefPubMed Rockall AG, Harris A, Wetton CW, Taube D, Gedroyc W, Al-Kutoubi MA. Stripping of failing haemodialysis catheters using the Ampltaz gooseneck snare. Clin Radiol. 1997;52:616–20.CrossRefPubMed
20.
go back to reference Silberzweig JE, Sacks D, Khorsandi AS, Bakal CW. Reporting standards for central venous access. Technology Assessment Committee. J Vasc Interv Radiol. 2000;11:391–400.CrossRefPubMed Silberzweig JE, Sacks D, Khorsandi AS, Bakal CW. Reporting standards for central venous access. Technology Assessment Committee. J Vasc Interv Radiol. 2000;11:391–400.CrossRefPubMed
21.
go back to reference Biffi R, Orsi F, Pozzi S, Pace U, Bonomo G, Monfardini L, et al. Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial. Ann Oncol. 2009;20:935–40.CrossRefPubMed Biffi R, Orsi F, Pozzi S, Pace U, Bonomo G, Monfardini L, et al. Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial. Ann Oncol. 2009;20:935–40.CrossRefPubMed
22.
go back to reference Biffi R, De Braud F, Orsi F, Pozzi S, Arnaldi P, Goldhirsch A, et al. A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer. 2001;92:1204–12.CrossRefPubMed Biffi R, De Braud F, Orsi F, Pozzi S, Arnaldi P, Goldhirsch A, et al. A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer. 2001;92:1204–12.CrossRefPubMed
23.
go back to reference Caers J, Fontaine C, Vinh-Hung V, De Mey J, Ponnet G, Oost C, et al. Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports. Support Care Cancer. 2005;13:325–31.CrossRefPubMed Caers J, Fontaine C, Vinh-Hung V, De Mey J, Ponnet G, Oost C, et al. Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports. Support Care Cancer. 2005;13:325–31.CrossRefPubMed
24.
go back to reference Puel V, Caudry M, Le Métayer P, Baste JC, Midy D, Marsault C, et al. Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports. Cancer. 1993;72:2248–52.CrossRefPubMed Puel V, Caudry M, Le Métayer P, Baste JC, Midy D, Marsault C, et al. Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports. Cancer. 1993;72:2248–52.CrossRefPubMed
25.
go back to reference Wun T, White RH. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors. Cancer Invest. 2009;27(Suppl 1):63–74.CrossRefPubMed Wun T, White RH. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors. Cancer Invest. 2009;27(Suppl 1):63–74.CrossRefPubMed
26.
go back to reference Kakkar AK, Levine M, Pinedo HM, Wolff R, Wong J. Venous thrombosis in cancer patients: insights from the FRONTLINE survey. Oncologist. 2003;8:381–8.CrossRefPubMed Kakkar AK, Levine M, Pinedo HM, Wolff R, Wong J. Venous thrombosis in cancer patients: insights from the FRONTLINE survey. Oncologist. 2003;8:381–8.CrossRefPubMed
27.
go back to reference Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore). 1999;78:285–91.CrossRef Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore). 1999;78:285–91.CrossRef
28.
go back to reference Falanga A, Zacharski L. Deep vein thrombosis in cancer: the scale of the problem and approaches to management. Ann Oncol. 2005;16:696–701.CrossRefPubMed Falanga A, Zacharski L. Deep vein thrombosis in cancer: the scale of the problem and approaches to management. Ann Oncol. 2005;16:696–701.CrossRefPubMed
29.
go back to reference Blom JW, Doggen CJM, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005 9;293:715–22.CrossRef Blom JW, Doggen CJM, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005 9;293:715–22.CrossRef
31.
go back to reference Gomes MPV, Deitcher SR. Diagnosis of venous thromboembolic disease in cancer patients. Oncology. 2003;17:126–135, 139. Gomes MPV, Deitcher SR. Diagnosis of venous thromboembolic disease in cancer patients. Oncology. 2003;17:126–135, 139.
32.
go back to reference Salwender HJ, Egerer G, Bach A, Hahn U, Goldschmidt H, Ho AD. Central venous catheter–related complications. Antibiot Chemother. 2000;50:133–43.CrossRefPubMed Salwender HJ, Egerer G, Bach A, Hahn U, Goldschmidt H, Ho AD. Central venous catheter–related complications. Antibiot Chemother. 2000;50:133–43.CrossRefPubMed
33.
go back to reference Tschirhart JM, Rao MK. Mechanism and management of persistent withdrawal occlusion. Am Surg. 1988;54:326–8.PubMed Tschirhart JM, Rao MK. Mechanism and management of persistent withdrawal occlusion. Am Surg. 1988;54:326–8.PubMed
34.
go back to reference Whigham CJ, Greenbaum MC, Fisher RG, Goodman CJ, Thornby JI, Thomas JW. Incidence and management of catheter occlusion in implantable arm ports: results in 391 patients. J Vasc Interv Radiol. 1999;10:767–74.CrossRefPubMed Whigham CJ, Greenbaum MC, Fisher RG, Goodman CJ, Thornby JI, Thomas JW. Incidence and management of catheter occlusion in implantable arm ports: results in 391 patients. J Vasc Interv Radiol. 1999;10:767–74.CrossRefPubMed
Metadata
Title
Local Low-Dose Thrombolysis for Safe and Effective Treatment of Venous Port-Catheter Thrombosis
Authors
Alexander Massmann, MD
Philippe Jagoda, MD
Nicole Kranzhoefer, MD
Arno Buecker, MD
Publication date
01-05-2015
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 5/2015
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-4129-0

Other articles of this Issue 5/2015

Annals of Surgical Oncology 5/2015 Go to the issue

Healthcare Policy and Outcomes

Mortality in Emergency Surgical Oncology